Impaired glucose tolerance, hyperinsulinaemia and DM are associated with increased risk of dementia or AD [1–8], and AD patients have been reported to have reduced insulin sensitivity [9], with insulin concentrations often found to be elevated in plasma and decreased in cerebrospinal fluid (CSF) [10, 11]. This evidence concerns the gene INS and Alzheimer disease.